Safe and Timely Antithrombotic Removal Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D): AProspective, Multi-center, Double-blind, Randomized, Study to Evaluate DrugSorb-ATR Removal ofApixaban and Rivaroxaban to Reduce Likelihood of Serious B

Project: Research project

Project Details

Description

Safe and Timely Antithrombotic Removal Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D): A Prospective, Multi-center, Double-blind, Randomized, Study to Evaluate DrugSorb-ATR Removal of Apixaban and Rivaroxaban to Reduce Likelihood of Serious B
StatusActive
Effective start/end date5/1/22 → 12/31/25

Funding

  • CYTOSORBENTS CORPORATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint